Moderna announces its decision to file patent infringement lawsuits against Pfizer and BioNTech in the United States District Court of Massachusetts and the Düsseldorf Regional Court in Germany.
In a press release, the laboratory explains that the Covid-19 vaccine from Pfizer and BioNTech, Comirnaty infringes patents filed by Moderna between 2010 and 2016 on Moderna’s mRNA.
Ensuring continued access to vaccines
Stéphane Bancel, CEO of Moderna, explains that his company invested “billions of dollars in creation and patenting in the decade before the Covid-19 pandemic.”
Recognizing the need to ensure continued access to these life-saving vaccines, Moderna says it is not seeking Comirnaty’s withdrawal from the market. Nor does the laboratory ask for a precautionary measure to prevent its future sale, nor for damages.
Source: BFM TV
